FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup